September 01, 2025 Keloid Scar Pathogenesis: New Insights Elevated PIEZO2 in keloid fibroblasts and endothelial cells correlates with collagen pathways and recurrence The Pathologist
August 22, 2025 Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma The ASCO Post
June 03, 2025 Dual Immunotherapy May Improve Progression-Free Survival in Advanced Squamous Cell Carcinoma The ASCO Post
May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
April 17, 2023 Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma The ASCO Post
June 23, 2023 SWOG S1512 Trial: Pembrolizumab Achieves High Response Rates in Rare Type of Melanoma The ASCO Post
August 22, 2025 Perceived Dermatologic Side Effects of Cancer Treatment: Pilot Survey Findings The ASCO Post
August 22, 2025 Use of Cemiplimab as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma The ASCO Post
April 26, 2024 New Social Media Trend Involving Freckle Tattoos May Conceal Early Signs of Skin Cancer Conexiant
April 29, 2024 Exposed to Agent Orange at US Bases, Veterans Face Cancer Without VA Compensation KFF Health News